Tafenoquine succinate

CAS No.	106635-81-8	Cat. No.	BCP44136
Name	Tafenoquine succinate
Synonyms	WR 238605 Succinatee; WR-238605, WR 238605, WR238605, SB-252263-AAB; SB252263-AAB; SB 252263-AAB;
Formula	C28H34F3N3O7	M. Wt	581.58

Description	Tafenoquine Succinate is an 8-aminoquinoline. Tafenoquine, also known as WR-238605, is an oral active antimalaria drug that is being investigated as a potential treatment for malaria, as well as for malaria prevention. Tafenoquine Shows Activity against Trypanosoma brucei. Tafenoquine targets leishmania respiratory complex III and induces apoptosis. Tafenoquine has a long half-life of approximately 14 days and is generally safe and well tolerated, Malaria remains an important cause of global morbidity and mortality. As antimalarial drug resistance escalates, new safe and effective medications are necessary to prevent and treat malarial infection.
Pathways	Microbiology/Virology
Targets	Antiparasitics

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.